SHS V holds first close on €90m

The vehicle was launched in March 2018 with a target of €150m, a 20% increase on SHS IV, which closed on €125m in May 2015, surpassing its €100m target.

SHS partner Hubertus Leonhardt said in a statement that the firm's positioning and track record as a sector specialist helped it attract commitments.

Investors
SHS said 50% of the commitments at first close came from existing investors, and it had particularly high demand from institutional investors and family offices. The European Investment Fund has backed SHS's previous vehicles.

Investments
SHS expects to make 12-15 investments from the new fund. It will invest a maximum of €30m per transaction in medical and diagnostic technology companies in the DACH region. With co-investors the maximum ticket size is up to €60m.

People
SHS Gesellschaft für Beteiligungsmanagement – Hubertus Leonhardt (partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Buyout
• Venture
• Healthcare
• DACH
• Germany